Eterna Therapeutics News

Eterna Therapeutics | 424B3: Prospectus

Jan 24 15:20

Eterna Therapeutics | EFFECT: Others

Jan 22 23:00

Eterna Therapeutics | 424B3: Prospectus

Aug 23, 2023 06:00

Eterna Therapeutics | EFFECT: Others

Aug 22, 2023 23:15

Eterna Therapeutics | 424B3: Prospectus

Apr 25, 2023 08:01

Eterna Therapeutics | EFFECT: Others

Apr 24, 2023 23:15

Eterna Therapeutics | 424B3: Prospectus

Mar 21, 2023 07:38

Eterna Therapeutics | EFFECT: Others

Mar 20, 2023 23:15

Brooklyn ImmunoTherapeutics | 424B3: Prospectus

May 12, 2022 08:00

Brooklyn ImmunoTherapeutics | EFFECT: Others

May 11, 2022 23:15

Brooklyn ImmunoTherapeutics | EFFECT: Others

Nov 28, 2021 23:15

Brooklyn ImmunoTherapeutics | 424B3: Prospectus

Nov 26, 2021 11:47

Brooklyn ImmunoTherapeutics | 8-A12B/A: Registration of a class of securities on a national securities exchange (Amendment)

Nov 18, 2021 15:51

Brooklyn ImmunoTherapeutics | 8-A12B: Registration of a class of securities on a national securities exchange

Oct 22, 2021 15:12

Brooklyn ImmunoTherapeutics | EFFECT: Others

Jun 6, 2021 23:15

Brooklyn ImmunoTherapeutics | 424B3: Prospectus

Jun 4, 2021 11:21

Brooklyn ImmunoTherapeutics | 424B3: Prospectus

May 11, 2021 15:31

Brooklyn ImmunoTherapeutics | EFFECT: Others

May 10, 2021 23:15

Eterna Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 8, 2021 06:05

Eterna Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Feb 26, 2021 15:30